Workup and Empiric Treatment for Female Patient with Dysuria
For a female patient with dysuria and adequate renal function, perform urinalysis to guide management, and if uncomplicated cystitis is suspected (dysuria with frequency/urgency, no fever, no flank pain, no vaginal discharge), initiate empiric treatment with nitrofurantoin 100 mg twice daily for 5 days or fosfomycin 3g single dose. 1, 2
Initial Clinical Assessment
The key to managing dysuria is distinguishing between uncomplicated cystitis, complicated UTI, pyelonephritis, and non-infectious causes through targeted history:
Look specifically for:
- Fever >38°C, flank pain, costovertebral angle tenderness → suggests pyelonephritis, not simple cystitis 1
- Vaginal discharge or pruritus → significantly decreases likelihood of UTI; investigate for cervicitis or sexually transmitted infections 3, 4
- Risk factors for complicated UTI: male sex, pregnancy, diabetes, immunosuppression, recent instrumentation, known urological abnormalities, history of multidrug-resistant organisms 1
High probability of uncomplicated cystitis exists when: dysuria plus urinary frequency/urgency WITHOUT fever, flank pain, or vaginal symptoms 4
Diagnostic Workup
Urinalysis should be performed in most patients presenting with dysuria 1, 3. The exception is young, healthy women with classic symptoms (dysuria, frequency, urgency) and no complicating factors—these patients can be treated empirically without testing 5.
Urine culture is specifically indicated for:
- Suspected pyelonephritis (always required) 1
- Symptoms not resolving or recurring within 4 weeks after treatment 1
- Atypical symptoms 1
- Pregnant women 1
- Suspected complicated UTI 1
Do NOT routinely perform post-treatment urinalysis or cultures in asymptomatic patients 1.
Empiric Treatment for Uncomplicated Cystitis
First-line options (choose based on local resistance patterns and patient factors) 1, 2:
- Fosfomycin trometamol 3g single dose (most convenient)
- Nitrofurantoin 100 mg twice daily for 5 days (preferred to spare broader-spectrum agents)
- Pivmecillinam 400 mg three times daily for 3-5 days
Alternative options (if resistance rates for E. coli <20%) 1:
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days
- Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days)
Critical caveat: Fluoroquinolones should NOT be first-line for uncomplicated cystitis due to ecological concerns and should be reserved for more serious infections 2.
If Pyelonephritis is Suspected
Outpatient oral treatment (for mild-moderate cases without sepsis) 1:
- Ciprofloxacin 500-750 mg twice daily for 7 days (if local fluoroquinolone resistance <10%)
- Levofloxacin 750 mg daily for 5 days
- Cefpodoxime 200 mg twice daily for 10 days OR Ceftibuten 400 mg daily for 10 days
- If using oral cephalosporins empirically, give initial IV dose of long-acting agent (e.g., ceftriaxone) first 1
Inpatient IV treatment (for severe symptoms, inability to tolerate oral, or sepsis) 1:
- Ceftriaxone 1-2g daily
- Ciprofloxacin 400 mg twice daily IV
- Levofloxacin 750 mg daily IV
Common Pitfalls to Avoid
Do not treat asymptomatic bacteriuria (positive culture without symptoms)—this leads to unnecessary antibiotic use 6
Do not use nitrofurantoin, fosfomycin, or pivmecillinam for pyelonephritis—insufficient data on efficacy for upper tract infections 1
If vaginal discharge is present, perform pelvic examination and test for cervicitis/STIs rather than empirically treating for UTI 3
For treatment failures: assume organism is not susceptible to initial agent; obtain culture and use different antibiotic class for 7 days 1
Avoid empiric broad-spectrum agents (carbapenems, antipseudomonal agents) unless risk factors for multidrug-resistant organisms exist 1, 2
Follow-up Strategy
If symptoms do not resolve by end of treatment OR recur within 2 weeks: obtain urine culture with susceptibility testing and retreat with different agent for 7 days 1. Consider imaging (ultrasound) if history of urolithiasis, renal dysfunction, or persistent fever after 72 hours of appropriate treatment 1.